Natural product-based drug discovery - Epothilones as lead structures for the discovery of new anticancer agents

• Published in: Chimia Vol. 58; no. 10; pp. 686 - 690
• Main Authors: Altmann, KH, Florsheimer, A, Bold, G, Caravatti, G, Wartmann, M
• Format: Journal Article
• Language: English
• Published: BERN Swiss Chemical Soc 01.10.2004; Swiss Chemical Society
• Subjects: Antiproliferative activity; Antitumor activity; Chemistry; Chemistry, Multidisciplinary; Epothilones; Natural products; Physical Sciences; Science & Technology; Structure activity relationships; natural products; MICROTUBULE-STABILIZING AGENTS; RESISTANT; epothilones; structure-activity relationships; antitumor activity; TUBULIN; antiproliferative activity; PACLITAXEL
• ISSN: 0009-4293; 2673-2424
• DOI: 10.2533/000942904777677317

Epothilones are microtubule depolymerization inhibitors, which inhibit the growth of a broad range of human cancer cell lines in vitro with low nM or sub-nM IC(50)s. Unlike other cytotoxic anticancer agents, epothilones are also active in vitro against multidrug-resistant cell lines and they inhibit the growth of multidrug-resistant tumors in vivo. In order to further our understanding of the structural requirements for biological activity and, ultimately, to identify new microtubule-stabilizing agents with improved overall properties, we have investigated the biological activity of a variety of structurally modified epothilone analogs. This report will focus on two selected aspects of our SAR work, namely (1) the synthesis and biological characterization of a series of 12-aza epothilones and (2) analogs with a conformationally constrained side-chain. Several of these structures exhibit potent in vitro anti proliferative activity, and thus may be interesting candidates for further profiling in tumor models and perhaps for the development of improved clinical candidates.